BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 23477861)

  • 1. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
    Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
    Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
    Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
    Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
    Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A
    Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.
    Brown RG; Lacomblez L; Landwehrmeyer BG; Bak T; Uttner I; Dubois B; Agid Y; Ludolph A; Bensimon G; Payan C; Leigh NP;
    Brain; 2010 Aug; 133(Pt 8):2382-93. PubMed ID: 20576697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
    Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
    Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gray matter correlates of behavioral severity in progressive supranuclear palsy.
    Josephs KA; Whitwell JL; Eggers SD; Senjem ML; Jack CR
    Mov Disord; 2011 Feb; 26(3):493-8. PubMed ID: 21462261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease.
    Somme J; Gómez-Esteban JC; Tijero B; Berganzo K; Lezcano E; Zarranz JJ
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1230-3. PubMed ID: 23253819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlations of microstructural changes in progressive supranuclear palsy.
    Tessitore A; Giordano A; Caiazzo G; Corbo D; De Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Neurobiol Aging; 2014 Oct; 35(10):2404-10. PubMed ID: 24786632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy.
    Boelmans K; Holst B; Hackius M; Finsterbusch J; Gerloff C; Fiehler J; Münchau A
    Mov Disord; 2012 Mar; 27(3):421-7. PubMed ID: 22290788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray matter correlations of cognition in incident Parkinson's disease.
    Dalaker TO; Zivadinov R; Larsen JP; Beyer MK; Cox JL; Alves G; Bronnick K; Tysnes OB; Antulov R; Dwyer MG; Aarsland D
    Mov Disord; 2010 Apr; 25(5):629-33. PubMed ID: 20213820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia.
    Sanchez-Castaneda C; Rene R; Ramirez-Ruiz B; Campdelacreu J; Gascon J; Falcon C; Calopa M; Jauma S; Juncadella M; Junque C
    Mov Disord; 2009 Sep; 24(12):1740-6. PubMed ID: 19569130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism.
    Camicioli R; Gee M; Bouchard TP; Fisher NJ; Hanstock CC; Emery DJ; Martin WR
    Parkinsonism Relat Disord; 2009 Mar; 15(3):187-95. PubMed ID: 18573676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling trajectories of regional volume loss in progressive supranuclear palsy.
    Josephs KA; Xia R; Mandrekar J; Gunter JL; Senjem ML; Jack CR; Whitwell JL
    Mov Disord; 2013 Jul; 28(8):1117-24. PubMed ID: 23568852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy.
    Yamauchi H; Fukuyama H; Nagahama Y; Katsumi Y; Dong Y; Konishi J; Kimura J
    Ann Neurol; 1997 May; 41(5):606-14. PubMed ID: 9153522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.